Stevens Capital Management LP Takes $664,000 Position in Corteva, Inc. $CTVA

Stevens Capital Management LP bought a new position in shares of Corteva, Inc. (NYSE:CTVA) during the 3rd quarter, HoldingsChannel.com reports. The fund bought 9,811 shares of the company’s stock, valued at approximately $664,000.

Other institutional investors have also recently made changes to their positions in the company. Activest Wealth Management grew its stake in shares of Corteva by 118.3% in the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after buying an additional 200 shares during the period. True Wealth Design LLC increased its holdings in shares of Corteva by 209.5% during the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after acquiring an additional 264 shares in the last quarter. Total Investment Management Inc. acquired a new position in shares of Corteva during the second quarter worth approximately $27,000. Curat Global LLC lifted its holdings in shares of Corteva by 93.7% in the 2nd quarter. Curat Global LLC now owns 370 shares of the company’s stock worth $28,000 after purchasing an additional 179 shares in the last quarter. Finally, Twin Peaks Wealth Advisors LLC acquired a new stake in Corteva in the 2nd quarter valued at $29,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Price Performance

Shares of NYSE CTVA opened at $76.20 on Friday. The company has a market capitalization of $51.25 billion, a PE ratio of 48.23, a PEG ratio of 2.60 and a beta of 0.75. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The stock’s 50 day moving average price is $70.71 and its 200-day moving average price is $68.58. Corteva, Inc. has a twelve month low of $53.40 and a twelve month high of $77.41.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting analysts’ consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. During the same period last year, the company posted $0.32 earnings per share. Corteva’s quarterly revenue was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be given a dividend of $0.18 per share. The ex-dividend date is Monday, March 2nd. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio is presently 45.57%.

Wall Street Analysts Forecast Growth

CTVA has been the topic of several research reports. The Goldman Sachs Group restated a “buy” rating and set a $88.00 price objective on shares of Corteva in a report on Thursday, February 5th. CICC Research upped their target price on shares of Corteva from $70.00 to $80.00 and gave the stock an “outperform” rating in a report on Wednesday, February 11th. Royal Bank Of Canada lifted their price target on Corteva from $80.00 to $89.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th. Wolfe Research boosted their price objective on Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Finally, Bank of America lifted their target price on Corteva from $80.00 to $82.00 and gave the company a “buy” rating in a research report on Thursday, January 8th. Two analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $82.30.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.